FB2025_01 , released February 20, 2025
Human Disease Model Report: drug discovery and assessment (fly models overview)
Open Close
General Information
Name
drug discovery and assessment (fly models overview)
FlyBase ID
FBhh0001114
Disease Ontology Term
    Parent Disease
    OMIM
    Overview

    This report includes links to reviews and publications describing methods for drug discovery and assessment using Drosophila, typically using whole animals. Drosophila cells have also been used, providing an assay that avoids genetic redundancies present in mammalian systems (for example, FBrf0214389).

    [updated Oct. 2019 by FlyBase; FBrf0222196]

    Disease Summary Information
    Disease Summary: drug discovery and assessment (fly models overview)
    OMIM report
    Human gene(s) implicated
    Symptoms and phenotype
    Genetics
    Cellular phenotype and pathology
    Molecular information
    External links
      Disease synonyms
      Ortholog Information
      Human gene(s) in FlyBase
        Other mammalian ortholog(s) used
          D. melanogaster Gene Information (0)
          Other Genes Used: Viral, Bacterial, Synthetic (0)
            Summary of Physical Interactions (0 groups)
            Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
            Alleles Representing Disease-Implicated Variants
            Genetic Tools, Stocks and Reagents
            Sources of Stocks
            Contact lab of origin for a reagent not available from a public stock center.
            Bloomington Stock Center Disease Page
            Related mammalian, viral, bacterial, or synthetic transgenes
            Allele
            Transgene
            Publicly Available Stocks
            Selected Drosophila transgenes
            Allele
            Transgene
            Publicly Available Stocks
            RNAi constructs available
            Allele
            Transgene
            Publicly Available Stocks
            Selected Drosophila classical alleles
            Allele
            Allele class
            Mutagen
            Publicly Available Stocks
            References (128)